戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ha orthosteric antagonist (S)-alpha-methyl-4-carboxyphenylglycine.
2 the Group I (mGluR1/mGluR5) antagonist (S)-4-carboxyphenylglycine (4CPG) or mGluR1 antagonist (+)-2-m
3 ylglycine (4C3HPG; 100-200 microM) and (S)-4-carboxyphenylglycine (4CPG; 300 microM) did not reduce N
4 d by the selective mGluR1/5 antagonist (S)-4-carboxyphenylglycine (4CPG; 300 microM).
5 I mGluR antagonist MCPG [(RS)-alpha-methyl-4-carboxyphenylglycine, 50-500 mum] on persistent cellular
6 /II-specific antagonist (R,S)-alpha-methyl-4-carboxyphenylglycine and the group III-specific antagoni
7 incubating slices in the xCT inhibitor (S)-4-carboxyphenylglycine, and consistent with the idea that
8 is blockable by the glutamate analogue (S)-4-carboxyphenylglycine (CPG).
9 ansport system x(c)- with glutamate or (S)-4-carboxyphenylglycine in lung A549 and HOP-62, and ovaria
10                                 (S)-Methyl-4-carboxyphenylglycine, L-(+)-2-amino-3-phosphonopropionic
11 botropic receptors 1 (mGluR1), +/-2-methyl-4-carboxyphenylglycine (LY367385), and mGluR5, 2-methyl-6-
12 e (4CPG) or mGluR1 antagonist (+)-2-methyl-4-carboxyphenylglycine (LY367385).
13  the metabotropic antagonists alpha-methyl-4-carboxyphenylglycine (MCPG) and 1-aminoindan-1,5-dicarbo
14 The broad-spectrum antagonist alpha-methyl-4-carboxyphenylglycine (MCPG) and/or (RS)-alpha-cyclopropy
15 sm of group 1 mGluRs with (S)-alpha-methyl-4-carboxyphenylglycine (MCPG) did not result in shorter av
16 sensitive receptor antagonist alpha-methyl-4-carboxyphenylglycine (MCPG) does not block the actions o
17  past few years, the compound alpha-methyl-4-carboxyphenylglycine (MCPG) has been widely used to test
18 e receptor (mGluR) antagonist alpha-methyl-4-carboxyphenylglycine (MCPG) strongly attenuated LTP, res
19   The mGluR antagonist (R, S)-alpha-methyl-4-carboxyphenylglycine (MCPG) was infused into the hippoca
20 enzo[f]quinoxaline (NBQX) and alpha-methyl-4-carboxyphenylglycine (MCPG) were evaluated against neuro
21 fect of the infusion of (+/-)-alpha-methyl-4-carboxyphenylglycine (MCPG), a metabotropic glutamate re
22 lective mGluR antagonist, (S)-alpha-methyl-4-carboxyphenylglycine (MCPG), into the dorsal striatum at
23 glutamate receptor antagonist alpha-methyl-4-carboxyphenylglycine (MCPG).
24 broad spectrum mGluR antagonist (S)-Methyl-4-carboxyphenylglycine (MCPG).
25  by the mGluR antagonist (RS)-alpha-methyl-4-carboxyphenylglycine (MCPG; 500 microM) and by the selec
26  mGlu receptor antagonist (+)-alpha-methyl-4-carboxyphenylglycine (MCPG; 500 microM).
27 amate receptor antagonist (+)-alpha-methyl-4-carboxyphenylglycine ((+)-MCPG; 1000 microM) but was gre
28 ress SLC7A11, inhibition of SLC7A11 by (S)-4-carboxyphenylglycine or small interfering RNA increased
29                                          S-4-carboxyphenylglycine (S)-4CPG), an antagonist of group I
30  glutamate receptor agonist/antagonist (S)-4-carboxyphenylglycine (S-4CPG) potently and selectively i
31 PSP was partially or fully reversed by (S)-4-carboxyphenylglycine (S-4CPG), the mGlu subtype 1 prefer
32 dly acting mGluR antagonist S-alpha-methyl-4-carboxyphenylglycine (S-MCPG).
33 tracellular glutamine and inhibited by (S)-4-carboxyphenylglycine, which blocked cystine-glutamate ex

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。